Trials / Terminated
TerminatedNCT01565590
Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to compare patients with aneurysmal subarachnoid hemorrhage on dexmedetomidine compared to propofol to assess if one group has decreased inflammation. The investigators hypothesis is that the group assigned to receive dexmedetomidine will have a more profound decrease in markers of inflammation over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | 0.2-1.5 mcg/kg/hr |
| DRUG | propofol | 5-80 mcg/kg/min |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2012-03-28
- Last updated
- 2018-02-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01565590. Inclusion in this directory is not an endorsement.